Projected Income Statement: Amgen Inc.

Forecast Balance Sheet: Amgen Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 25,272 29,640 53,669 48,126 45,475 41,673 36,759 31,482
Change - 17.28% 81.07% -10.33% -5.51% -8.36% -11.79% -14.36%
Announcement Date 2/7/22 1/31/23 2/6/24 2/4/25 2/3/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Amgen Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 880 936 1,112 1,096 1,858 2,644 2,194 2,169
Change - 6.36% 18.8% -1.44% 69.53% 42.28% -17% -1.13%
Free Cash Flow (FCF) 1 8,381 8,785 7,359 10,394 8,100 12,853 14,769 15,178
Change - 4.82% -16.23% 41.24% -22.07% 58.68% 14.91% 2.77%
Announcement Date 2/7/22 1/31/23 2/6/24 2/4/25 2/3/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Amgen Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 60.9% 61.46% 61.97% 61.69% 58.15% 56.71% 55.71% 53.98%
EBIT Margin (%) 47.82% 48.48% 47.53% 44.96% 44.09% 43.69% 43.94% 44%
EBT Margin (%) 25.79% 27.91% 27.86% 13.79% 24.42% 24.67% 26.78% 27.62%
Net margin (%) 22.68% 24.89% 23.83% 12.24% 20.98% 21.75% 22.84% 23.34%
FCF margin (%) 32.26% 33.37% 26.11% 31.1% 22.04% 34.06% 38.2% 38.21%
FCF / Net Income (%) 142.22% 134.08% 109.56% 254.13% 105.04% 156.6% 167.24% 163.71%

Profitability

        
ROA 15.79% 15.16% 12.37% 11.36% 12.98% 11.03% 11.59% 11.8%
ROE 121.63% 184.73% 202.85% 177.29% 162.88% 123.07% 103.61% 92.83%

Financial Health

        
Leverage (Debt/EBITDA) 1.6x 1.83x 3.07x 2.33x 2.13x 1.95x 1.71x 1.47x
Debt / Free cash flow 3.02x 3.37x 7.29x 4.63x 5.61x 3.24x 2.49x 2.07x

Capital Intensity

        
CAPEX / Current Assets (%) 3.39% 3.56% 3.94% 3.28% 5.06% 7.01% 5.68% 5.46%
CAPEX / EBITDA (%) 5.56% 5.79% 6.37% 5.32% 8.69% 12.35% 10.19% 10.12%
CAPEX / FCF (%) 10.5% 10.65% 15.11% 10.54% 22.94% 20.57% 14.86% 14.29%

Items per share

        
Cash flow per share 1 16.16 17.97 15.75 21.24 18.37 26.95 24.78 25.98
Change - 11.18% -12.37% 34.89% -13.49% 46.68% -8.04% 4.84%
Dividend per Share 1 7.04 7.76 8.52 9 9.52 10.09 10.66 11.12
Change - 10.23% 9.79% 5.63% 5.78% 5.95% 5.66% 4.37%
Book Value Per Share 1 12.01 6.856 11.65 10.94 16.06 19.82 23.63 28.64
Change - -42.9% 69.91% -6.05% 46.77% 23.39% 19.21% 21.23%
EPS 1 10.28 12.11 12.49 7.56 14.23 15.23 16.6 17.27
Change - 17.8% 3.14% -39.47% 88.23% 7.01% 8.98% 4.07%
Nbr of stocks (in thousands) 563,266 533,579 535,178 537,533 538,481 539,708 539,708 539,708
Announcement Date 2/7/22 1/31/23 2/6/24 2/4/25 2/3/26 - - -
1USD
Estimates
2026 *2027 *
P/E 25.5x 23.4x
PBR 19.6x 16.4x
EV / Sales 6.65x 6.36x
Yield 2.6% 2.75%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
387.64USD
Average target price
357.03USD
Spread / Average Target
-7.90%

Quarterly revenue - Rate of surprise